ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s stock price passed above its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. ProtoKinetix shares last traded at $0.0001, with a volume of 50,000 shares changing hands.
ProtoKinetix Trading Down 100.0%
About ProtoKinetix
ProtoKinetix’s principal product candidate is PKX-001, an engineered glycopeptide being evaluated for potential applications in areas such as cell and tissue preservation, regenerative medicine, and the support of cellular therapies.
Recommended Stories
- Five stocks we like better than ProtoKinetix
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
